In single-ascending dose study in VWD patients, a subcutaneous dose of VGA039 was associated with substantial reductions in bleeds ...

Antiphospholipid antibodies (present in the serum of patients with APS) are known to induce platelet activation and the production of procoagulants such as von Willebrand factor, thereby ...

The Role of the von Willebrand Factor Collagen-Binding Assay (VWF:CB) in the Diagnosis and Treatment of von Willebrand Disease (VWD) and Way Beyond: A Comprehensive 36-Year History.